Prevalence-Based Measurement of the Economic Burden of Rare Diseases: Case Review To Determine the Annual Cost of Acromegaly In France
Value Health
.
2014 Nov;17(7):A527.
doi: 10.1016/j.jval.2014.08.1666.
Epub 2014 Oct 26.
Authors
E Tasdemir
1
,
M Magestro
2
,
B P Griner
3
,
G Cummins
4
,
Engen A Van
5
,
J Kreeftmeijer
5
,
J Niemira
3
,
C Tao
6
Affiliations
1
Novartis Oncology, Origgio / VA, Italy.
2
Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
3
Quintiles, Cambridge, MA, USA.
4
Quintiles, Durham, NC, USA.
5
Quintiles Consulting, Hoofddorp, The Netherlands.
6
Quintiles Consulting, Cambridge, MA, USA.
PMID:
27201667
DOI:
10.1016/j.jval.2014.08.1666
No abstract available